Role of quantitative bone scanning in the assessment of bone turnover in patients with Charcot foot

Diabetes Care. 2010 Feb;33(2):348-9. doi: 10.2337/dc09-0950. Epub 2009 Nov 23.

Abstract

Objective: To assess the new quantitative bone scan parameters as markers of Charcot neuroosteoarthropathy (CNO) activity.

Research design and methods: Forty-two patients with acute (n = 21) and nonacute (n = 21) CNO underwent quantitative bone scanning. Patients with acute CNO were followed for 3-12 months and bone scans were repeated after treatment. New quantitative parameters were assessed and compared with markers of bone turnover and with skin temperature difference (STD).

Results: Significant correlations between quantitative bone scan parameters and bone turnover markers were observed (all P < 0.05). These parameters decreased after treatment of CNO, and its reduction to the baseline value correlated with differences of bone turnover markers and STD (all P < 0.05).

Conclusions: Our study suggests that bone scanning can be used not only for diagnosis of CNO but also for monitoring disease activity by quantitative bone scan parameters.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bone and Bones / diagnostic imaging*
  • Bone and Bones / metabolism
  • Diabetes Complications / diagnostic imaging
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / diagnostic imaging
  • Female
  • Gait Disorders, Neurologic / diagnostic imaging*
  • Humans
  • Male
  • Middle Aged
  • Perception
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • Technetium Tc 99m Medronate*
  • Vibration

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Medronate